September 2026Search for patent licensing royalty rates by industry and you get the same table everywhere. Semiconductors low, software high, pharma somewhere in between. The table is not wrong. It is just answering a different question from the one a licensor is asking. Those bands blend every kind of deal into one number per sector: exclusive product licences with engineering support, settlement agreements, and bare patent licences where nothing but the right to practise the claims changes hands. Pull the deals apart and a more useful picture appears. Industry sets the neighbourhood. The kind of licence you are offering sets the address. Here is what the published data says for each sector, and how to find the number that belongs to your patent. ## Royalty rates by industry at a glance The most widely quoted bands come from survey summaries, which put software and SaaS at roughly 5 to 8 percent, pharmaceuticals and biotech at 4 to 6 percent, medical devices at 3 to 5 percent, electronics and chemicals at 2 to 4 percent, automotive and industrial at 1 to 3 percent, and semiconductors at 1 to 2 percent. The source itself labels them survey figures without per-row provenance. For measured numbers, the best free dataset is a study of 2,963 royalty-bearing licences filed with the US Securities and Exchange Commission from 1994 to 2009, including more than 800 previously redacted agreements obtained under the Freedom of Information Act. It reports medians by industry and, crucially, by type of licence. Averages sit above the medians in almost every cell, a sign of a long right tail. | Industry | Published band | Bare patent median | Patent plus know-how median | | --- | --- | --- | --- | | Software | 5 to 8% | 3.0% (17 deals) | 4.0% (17 deals) | | Hardware and electronics | 2 to 4% | 3.5% (56 deals) | 4.4% (95 deals) | | Medical devices | 3 to 5% | 3.5% (73 deals) | 5.0% (109 deals) | | Pharmaceuticals | 4 to 6% | 3.0% (197 deals) | 4.5% (349 deals) | | All industries | 3 to 6% | 3.0% (343 deals) | 4.5% (570 deals) | Look down the bare patent column. Across four very different industries the median barely moves, from 3.0 to 3.5 percent. The spread in the published bands comes mostly from what else travels with the patent. The paid benchmark most practitioners buy, the RoyaltySource summary, covers 14 industries over more than 30 years with averages, medians and interquartile ranges, drawn from SEC EDGAR filings and other public records. If you need a defensible figure for a valuation report, that interquartile range is worth the fee. For a first negotiation position, the free data above gets you most of the way. ## What the data says, sector by sector ### Pharmaceuticals and biotech A separate study by Micronomics of 90 pharmaceutical licences found a mean of 5.66 percent and a median of 4.38 percent, with 3 percent the single most common rate; averages rose from 5.21 percent in the 1980s and early 1990s to 8.52 percent in agreements from 2002 to 2006, while 77 medical device licences averaged 4.35 percent with a 4 percent median and 21 chemical licences averaged 3.70 percent with a 3 percent median. Two cautions. Most of those agreements bundled know-how, copyright or trademarks with the patent. And stage matters more in pharma than anywhere else: a compound in late clinical development licenses on different terms from an early molecule. The published bands note late-stage assets reach double digits. A preclinical patent does not. ### Medical devices Devices look steady at 3 to 5 percent in almost every source, but the sub-rows show a gap worth knowing. In the SEC dataset, electromedical apparatus licences with know-how had a 5.0 percent median against 2.0 percent for bare patents. That is the widest know-how premium in the study. A device patent without the clinical data, design files or regulatory history behind it is a much smaller asset to a licensee. ### Software Software carries the highest headline band and one of the lowest bare patent medians. The reason is the deal mix. Software product and distribution licences in the SEC data had a median of 14.4 percent, pulling the sector average up, while a patent-only software licence sat at 3.0 percent. Sample sizes for software patent licences are small, so treat that 3 percent as indicative rather than settled. Margins explain why software can pay more when the patent covers a real share of the product. Benchmark tools tie rates to gross margin, around 80 percent in software against around 12.5 percent in automotive, with royalties above 3 to 5 percent seriously eroding profit in thin-margin sectors; standard-essential telecom patents instead use per-unit fees such as 2.50 to 5.00 dollars per 5G device or 20 to 32 dollars per connected vehicle. ### Electronics, hardware and semiconductors Semiconductors are the low end for a structural reason: many patents read on one chip, and each patent is a small slice of the product's value. In the SEC data, semiconductor licences with know-how had a median of 3.5 percent and bare patent licences 2.4 percent. Broader hardware, which includes electronic components, instrumentation and telecom equipment, sat at 3.5 percent for bare patents. ### Chemicals Chemicals cluster tightly. The Micronomics sample put most rates between 3 and 6 percent with a 3 percent median. Process patents often compete with alternative routes to the same product, which caps what a licensee will pay. ### Automotive, telecom and aerospace Automotive sits low because margins are thin and a car combines a great many patented features. Telecom has largely left percentage rates behind for the per-unit fees above. Aerospace is the surprise. In the combined Licensing Executives Society surveys, aerospace technology had the highest average royalty rate at 10.7 percent, and aerospace, software, medical and healthcare technologies all carried significant royalty premiums, as did exclusive licences and fully developed technology. Few licensees, long qualification cycles and high switching costs reward a patent that is already designed in. ## Why deal type moves the rate more than industry The SEC study is blunt about it. Across all industries, median rates ran from 3.0 percent for bare patent licences to 10.0 percent for product and distribution licences, more than a threefold gap, and that ranking held in every industry examined. No industry spread in the table above comes close. Four patterns from the same dataset matter for pricing: - Know-how earns a premium. Patent plus know-how licences had a 4.5 percent median against 3.0 percent for bare patents across all industries.
We use essential cookies to operate this website and, with your consent, optional cookies to understand site usage. You can accept or decline non-essential cookies at any time. See our Impressum for our contact and legal details.